Mintz Advises On $39 Million Private Placement Concurrent With Scancell Holdings And Neuphoria Therapeutics’ Merger Transaction

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Explore Firm Details

Mintz advised placement agents on a $39 million private placement as part of an $89 million financing package supporting the merger between Scancell Holdings plc and Neuphoria Therapeutics Inc. The transaction involves a combination of equity and debt fin

United States

Mintz advised the placement agents in connection with the $39 Million private placement that is expected to close in connection with the completion of the merger transaction between Scancell Holdings plc and Neuphoria Therapeutics Inc. The private placement is part of up to $89 Million of financing expected to be raised by Scancell in connection with the merger transaction through a combination of equity and debt.

Leerink Partners, TD Cowen and H.C. Wainwright & Co. are acting as placement agents for the private placement.

The Mintz capital markets team included William Hicks, John Rudy, Nishant Dharia, and Zach Irwin. Members of the Mintz team are based in Boston and New York.

Contributor

Explore Firm Details

See More Popular Content From